ArticleAnimal models and experimental medicine2026
An ultra-processed food-based cafeteria diet induces obesity, metabolic dysfunction, and tissue-specific gene dysregulation in C57BL/6 mice.
Article in Animal models and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThe cafeteria diet (CAFD) model has been used to mimic the Western-style "junk food" eating pattern, inducing obesity in rodents. As the dietary composition varies across studies, we developed a CAFD model based on commonly consumed Brazilian ultra-processed foods to evaluate its effect on weight gain, metabolic parameters, and gene expression in C57BL/6 mice.
methodsForty male C57BL/6 mice were assigned to either a standard diet (SD) group or a CAFD group for 16 weeks. Biometric data, glycemic control, insulin resistance (IR), hepatic steatosis, and serum leptin and adiponectin levels were assessed. Expressions of 27 genes involved in adipocytokine signaling, inflammation, apoptosis, lipid, and glucose metabolism were analyzed using quantitative real-time polymerase chain reaction in visceral (VAT) and subcutaneous (SAT) adipose tissues, liver, and skeletal muscle.
resultsCAFD-fed mice exhibited significantly greater weight gain, hyperglycemia, elevated IR, and hepatic steatosis compared to SD controls. Circulating leptin and adiponectin levels increased in the CAFD group. Gene expression analysis revealed significant dysregulation in VAT (19 genes), SAT (6 genes), liver (11 genes), and muscle (4 genes) of the CAFD group, affecting pathways related to adipocytokine signaling, oxidative stress, inflammation, apoptosis, and lipid and glucose metabolism. Additionally, an increased Itgax-to-Llgl1 ratio in VAT of the CAFD mice indicated a phenotypic shift in macrophages from M2 to pro-inflammatory M1.
conclusionThis CAFD model efficiently induces obesity, metabolic dysfunction, and tissue-specific alterations in gene expression in C57BL/6 mice, supporting its use as a relevant model for studying the molecular and inflammatory mechanisms underlying diet-induced obesity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.